Volume 16, Issue 3 (Scientific Journal of Hamadan University of Medical Sciences-Autumn 2009)                   Avicenna J Clin Med 2009, 16(3): 16-20 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faghani M, Mohammad Ghasemi F, Nasiri E, Nikbakht M. Investigation of Intron 3 Polymorphism of p53 in Breast Cancer Patients in Isfahan. Avicenna J Clin Med. 2009; 16 (3) :16-20
URL: http://sjh.umsha.ac.ir/article-1-305-en.html
1- , mfaghani@gums.ac.ir
Abstract:   (3062 Views)

Introduction & Objective: Genetic agents play important roles in developing of cancers. Mutations and polymorphism affects on p53 protein function in suppressing tumor. We aimed to investigate the intron 3 polymorphism of p53 in Isfahanian breast invasive ductal carcinoma.

Materials & Methods: We undertook a case–control study on 192 controls and 192 patients with breast invasive ductal carcinoma from Isfahan. p53 intron 3 genotypes were identified using allele-specific PCR. The c2-test was used to assess the statistical significance of the data.

Results: In control samples, the genotype distribution for p53 intron 3 polymorphisms was 57.3% and 42.7% for the A1/A2 and A1/A1 genotypes, respectively. In the cancer group, 85.4% of the cases were A1/A2 and 14.6% were A1/A1. The differences in the distribution of the p53 intron 3 polymorphism between the cases and controls were statistically significant (P<0.001).

Conclusion: Our findings indicated that p53 intron 3 polymorphism probably is a genetic predisposing factor for breast invasive ductal carcinoma development in Isfahanian specimens.

Full-Text [PDF 235 kb]   (1462 Downloads)    
Type of Study: Original | Subject: Other Clinical Specialties

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb